MSH2 and neoplasm: Additionally, Sanger sequencing of the tumor and blood DNA revealed significant reduction of the normal allele peak in the tumor, indicating that the second MSH2 inactivation event probably occurred due to deletion of the normal allele, causing loss of heterozygosity (LOH; Figure S2).